Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,623 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04959838Recruiting
Study of job stress in eye doctors and trainees
This study looks at job stress among ophthalmologists (eye doctors) and ophthalmology residents. It may help improve working conditions and support for people in eye care.
Clermont-FerrandAges 18–65 - NCT04737889RecruitingPhase 2
Rituximab plus lenalidomide, methotrexate, and temozolomide for brain lymphoma
This Phase 2 study tests a combination treatment to shrink primary central nervous system lymphoma that starts in the brain, spinal cord, meninges, or eye. It may help patients who have not had anti-cancer treatment yet, but it requires specific cancer type and health conditions.
Zhengzhou, HenanAges 18–70 - NCT05218785Recruiting
Botulinum toxin for calf tightness and long-term heel pain
This trial tests whether injections of botulinum toxin A can loosen a tight calf muscle and improve long-lasting plantar fasciitis (heel/foot pain). It’s for people whose symptoms have lasted at least a year and who haven’t improved enough with physical therapy.
Oslo, OsloAges 18–75 - NCT05030259Recruiting
Study of recovery after thigh artery injuries
This trial looks at outcomes in adults who have injuries to the femoropopliteal (thigh-to-knee) artery. It may help doctors understand what affects recovery and discharge, especially for preventing complications.
Shijiazhuang, HebeiAges 18 years+ - NCT05096715RecruitingPhase 1
Testing atezolizumab plus bevacizumab with SBRT for advanced liver cancer
This Phase 1 trial tests how well a combination treatment works for liver cancer that cannot be removed with surgery or other local treatments. It combines two immune/targeted medicines with a focused type of radiation (SBRT) to control the tumors.
Boston, MassachusettsAges 18 years+ - NCT05248620Recruiting
Antibiotics to prevent infections in hemodialysis catheters
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
Copenhagen, Capital RegionAges 18 years+ - NCT05054829Recruiting
Social skills group for adults with autism
This trial tests whether a structured social skills training group can improve relationships for adults on the autism spectrum. It may help you practice real-life social situations with guided group support.
TaipeiAges 18–45 - NCT05227183Recruiting
VIGILANS support to prevent repeat suicidal behavior
This study tests a monitoring-and-support approach called VIGILANS to help prevent suicidal behaviors from returning. It focuses on whether people can stay safer with extra follow-up and restoring social connection after a recent suicide attempt (or not).
MontpellierAges 18–55 - NCT05224960RecruitingPhase 2
Stem cell treatment for worsening liver cirrhosis
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Lanzhou, GansuAges 18–75 - NCT04886401Recruiting
Study predicting response to pembrolizumab in advanced lung cancer
This study looks back at prior treatment to learn which patients with advanced non-small cell lung cancer (NSCLC) are more likely to respond to pembrolizumab, an immune therapy given up front. The results may help doctors better predict who benefits from this treatment.
BrestAges Any age - NCT04954404Recruiting
Mitral valve procedure registry for Chinese patients in one center
This study is a registry (a way to track real-world outcomes) for people with mitral valve disease who receive a mitral valve procedure. It helps doctors understand how well these procedures work and what complications happen in patients like you.
Hangzhou, ZhejiangAges 18 years+ - NCT04965558Recruiting
Study of outcomes in genetic Wilson disease patients
This study looks at the health features and long-term outcomes in people with Wilson disease who have a genetic diagnosis. It may help doctors understand what to expect over time for different patients.
Hangzhou, ZhejiangAges 6–65 - NCT05234463Recruiting
Study links complement activity to IgA kidney disease severity
This study looks at how parts of the immune system (called complement) may relate to how severe IgA kidney disease is. It may help doctors understand disease activity better, even if the study is mainly observational.
StrasbourgAges 18 years+ - NCT05074316Recruiting
Study to learn how blood cancers progress
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT05246657Recruiting
EUS procedure to bypass blocked bile ducts when ERCP fails
This trial studies a new way to access the bile ducts using a scope guided by ultrasound when standard ERCP can’t be done or doesn’t work. It may help people with non-cancer (benign) bile duct blockages get the bile flowing again.
ValladolidAges 18 years+ - NCT04723888Recruiting
Supplements to slow aneurysm growth and prevent rupture
This trial studies whether alpha-ketoglutarate, a supplement, can slow the growth of an abdominal aortic aneurysm and reduce the risk of rupture. It may help people whose aneurysm size is in a specific range by tracking changes over time and watching for safety.
ShanghaiAges 50 years+ - NCT05000723Recruiting
Follow-up for hip joint infection after joint replacement
This study checks what happens over the long term for people who had an infection around a replaced (prosthetic) hip. It mainly helps doctors understand recovery and long-term outcomes after treatment.
LeuvenAges 18 years+ - NCT05183230Recruiting
Mobile program to help prevent suicide after hospital stay
This trial tests a phone-based (mobile) support program for middle-aged and older adults after a recent hospital stay for suicidal thoughts or an attempt. The goal is to reduce the chance of another suicidal crisis by providing structured support after discharge.
New York, New YorkAges 50–90 - NCT05495399Recruiting
Radiation after limited spine surgery for spine metastases
This study tests whether radiation given after limited surgery helps control cancer that has spread to a small area of the spine. It may help reduce tumor growth in the treated spine area and improve local control after operation.
TaipeiAges 20 years+ - NCT04763577Recruiting
Testing enzymes in ACE-inhibitor–related facial swelling
This trial studies what happens in the body’s enzyme system in people who get facial swelling (angioedema) from certain blood pressure medicines called ACE inhibitors. The goal is to better understand the cause and potentially guide safer treatment for future episodes.
GrenobleAges 18 years+ - NCT05078970Recruiting
Teen suicide intervention study for high-risk times
This study tests a suicide intervention approach for teens who are having suicidal thoughts or behaviors and are currently in an emergency or hospital setting. It may help you and your care team better support teens during the most risky period.
Columbus, OhioAges 11–17 - NCT05007834Recruiting
Study of sleep–hormone timing after chemotherapy-related missed periods
This study looks at how the body’s daily timing (circadian rhythms) may affect ovarian function and fertility after chemotherapy. It includes women who stopped having periods after chemotherapy and may help explain what to expect for post-cancer fertility.
LilleAges 25–35 - NCT05072262RecruitingPhase 4
Topical anti-inflammatory eye drops after corneal transplant
This study tests whether anti-inflammatory eye drops (nepafenac, an NSAID) can help reduce swelling in the macula (the sharp-vision part of the eye) after certain cornea transplant surgeries. It compares outcomes in adults having DSAEK or DMEK who can safely use the study drops.
OsloAges 18 years+ - NCT04989751Enrolling by invitation
Study of gene patterns in limb-girdle muscle weakness
This study looks at how specific gene changes relate to the pattern of muscle weakness in people with limb-girdle muscular dystrophy (LGMD). It may help doctors better understand the condition and improve future care.
ShanghaiAges 10 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,623 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.